KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Asset Utilization Ratio (2016 - 2025)

Rigel Pharmaceuticals has reported Asset Utilization Ratio over the past 14 years, most recently at 0.78 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 34.14% year-over-year to 0.78; the TTM value through Dec 2025 reached 0.78, down 34.14%, while the annual FY2025 figure was 0.87, 31.88% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.78 at Rigel Pharmaceuticals, down from 1.26 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 1.4 in Q2 2025 and troughed at 0.54 in Q1 2022.
  • A 5-year average of 0.96 and a median of 1.0 in 2023 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 34.55% in 2022 and later skyrocketed 87.13% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.84 in 2021, then grew by 14.09% to 0.96 in 2022, then grew by 4.45% to 1.01 in 2023, then grew by 17.57% to 1.18 in 2024, then tumbled by 34.14% to 0.78 in 2025.
  • Business Quant data shows Asset Utilization Ratio for RIGL at 0.78 in Q4 2025, 1.26 in Q3 2025, and 1.4 in Q2 2025.